Melanotan I and Melanotan II are both Skin & Pigmentation peptides, but they're studied for different things. In short, Melanotan I is a melanocortin agonist; the approved form treats a rare light-sensitivity disorder, while Melanotan II is a melanocortin agonist studied for skin pigmentation. This page compares the two side by side — what each is researched for, how mature the evidence is, and how they're typically used — so you can see where they overlap and where they differ. It's educational information only, not medical advice, and neither is a substitute for a conversation with a licensed professional.
Melanotan I vs Melanotan II at a glance
| Melanotan I | Melanotan II | |
|---|---|---|
| Category | Skin & Pigmentation | Skin & Pigmentation |
| In short | A melanocortin agonist; the approved form treats a rare light-sensitivity disorder. | A melanocortin agonist studied for skin pigmentation. |
| Researched for | Skin pigmentation, Photoprotection, EPP (approved use) | Skin pigmentation, Melanocortin pathway studies |
| Research status | Approved (as afamelanotide) for a specific rare condition. | Limited/early research; not an approved product. |
| Typically stacked with | — | — |
| Key consideration | The approved form is prescription-only for EPP. Unregulated tanning use is not medically endorsed. | Unregulated use raises safety concerns, including effects on moles and blood pressure. Not medically approved. |
How does Melanotan I work?
Melanotan I is a melanocortin agonist that stimulates melanin production. Its clinically developed form, afamelanotide (Scenesse), is approved to reduce phototoxic reactions in people with erythropoietic protoporphyria (EPP) by increasing protective pigmentation.
How does Melanotan II work?
Melanotan II is a synthetic analog of α-MSH that stimulates melanocytes to produce more melanin, driving skin pigmentation. Because it is a broad melanocortin agonist, it also interacts with appetite and sexual-function pathways.
Melanotan I vs Melanotan II: how to choose
Choosing between Melanotan I and Melanotan II really comes down to your specific goal — and it's a decision for you and a licensed professional, not something to settle from a web page. Melanotan I is most associated with Skin pigmentation and Photoprotection, while Melanotan II leans toward Skin pigmentation and Melanocortin pathway studies. Where they overlap, the practical differences are usually in mechanism and how far the research has actually progressed. Selpho provides no dosing or protocols; if you'd like a research-backed steer for your goals, the free Peptide Advisor is a good starting point.
Frequently asked questions
Both are Skin & Pigmentation peptides. Melanotan I is a melanocortin agonist; the approved form treats a rare light-sensitivity disorder; Melanotan II is a melanocortin agonist studied for skin pigmentation. They're most researched for Skin pigmentation, Photoprotection (Melanotan I) and Skin pigmentation, Melanocortin pathway studies (Melanotan II), respectively.
There's no universal "better" — it depends on your goal, and for most of these compounds robust head-to-head human evidence doesn't exist. The right choice is one made with a licensed professional. Selpho does not rank or prescribe; it offers educational information and a research-backed advisor.
They're in the same category, and combining research compounds is something to approach only with a licensed professional, since interactions and individual context matter. Selpho provides no dosing or protocols.
Melanotan I: Approved (as afamelanotide) for a specific rare condition. Melanotan II: Limited/early research; not an approved product.
Not sure which fits your goals?
Describe your situation and Selpho's free AI advisor will suggest research-backed peptides — no signup needed.
Try the Peptide AdvisorThis comparison is for educational purposes only and is not medical advice, a diagnosis, or a recommendation to use any compound. It contains no dosing or purchase information. Always consult a licensed healthcare professional before considering any peptide.